ABBVIE INC. - Daily - Technical analysis published on 09/23/2024 (GMT)
- 146
- 0
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : LEVEL MAINTAINED
Summary of the analysis
Additional analysis
Quotes
ABBVIE INC. rating 193.25 USD. The price is lower by -0.11% since the last closing and was traded between 192.20 USD and 194.30 USD over the period. The price is currently at +0.55% from its lowest and -0.54% from its highest.The Central Gaps scanner detects a bullish opening marking the presence of buyers ahead of sellers at the opening but not sufficiently marked to allow the price to register a quotation gap.
Bullish opening
Type : Bullish
Timeframe : Openning
So that you have an overall view of the price change, here is a table showing the variations over several periods:
Near a new HIGH record (5 years)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1 year)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1st january)
Type : Bullish
Timeframe : Weekly
Near a new HIGH record (1 month)
Type : Bullish
Timeframe : Weekly
Technical
Technical analysis of this Daily chart of ABBVIE INC. indicates that the overall trend is bullish. The signals given by moving averages are 71.43% bullish. This bullish trend could slow down given the neutral signals currently being given by short-term moving averages. The Central Indicators market scanner currently does not detect any result that concerns moving averages.
Technical indicators are slightly bearish. There is therefore considerable uncertainty about the continuation of the decline.
The Central Indicators scanner found this result concerning these indicators:
Momentum indicator is back over 0
Type : Bullish
Timeframe : Daily
Central Patterns, the market scanner focusing on chart patterns, resistances and supports found these results:
Near support of channel
Type : Bullish
Timeframe : Daily
Horizontal support is broken
Type : Bearish
Timeframe : Daily
The Central Candlesticks scanner which studies Japanese candlesticks did not detect anything.
S3 | S2 | S1 | Price | R1 | |
---|---|---|---|---|---|
ProTrendLines | 164.73 | 178.76 | 192.86 | 193.25 | 199.35 |
Change (%) | -14.76% | -7.50% | -0.20% | - | +3.16% |
Change | -28.52 | -14.49 | -0.39 | - | +6.10 |
Level | Minor | Major | Major | - | Major |
Attention could also be paid to pivot points to set price objectives:
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 190.77 | 191.45 | 192.46 | 193.14 | 194.15 | 194.83 | 195.84 |
Camarilla | 193.01 | 193.16 | 193.32 | 193.47 | 193.63 | 193.78 | 193.94 |
Woodie | 190.94 | 191.53 | 192.63 | 193.22 | 194.32 | 194.91 | 196.01 |
Fibonacci | 191.45 | 192.10 | 192.49 | 193.14 | 193.79 | 194.18 | 194.83 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 187.07 | 189.42 | 191.45 | 193.80 | 195.83 | 198.18 | 200.21 |
Camarilla | 192.27 | 192.67 | 193.07 | 193.47 | 193.87 | 194.27 | 194.68 |
Woodie | 186.90 | 189.34 | 191.28 | 193.72 | 195.66 | 198.10 | 200.04 |
Fibonacci | 189.42 | 191.10 | 192.13 | 193.80 | 195.48 | 196.51 | 198.18 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 171.54 | 177.29 | 186.80 | 192.55 | 202.06 | 207.81 | 217.32 |
Camarilla | 192.11 | 193.51 | 194.91 | 196.31 | 197.71 | 199.11 | 200.51 |
Woodie | 173.42 | 178.23 | 188.68 | 193.49 | 203.94 | 208.75 | 219.20 |
Fibonacci | 177.29 | 183.12 | 186.72 | 192.55 | 198.38 | 201.98 | 207.81 |
Numerical data
The following are the details of the technical indicators and moving averages that were collected to generate this technical analysis:
RSI (14): | 50.14 | |
MACD (12,26,9): | 0.9400 | |
Directional Movement: | 4.62 | |
AROON (14): | -50.00 | |
DEMA (21): | 195.87 | |
Parabolic SAR (0,02-0,02-0,2): | 197.43 | |
Elder Ray (13): | -0.96 | |
Super Trend (3,10): | 188.94 | |
Zig ZAG (10): | 193.35 | |
VORTEX (21): | 0.9200 | |
Stochastique (14,3,5): | 25.45 | |
TEMA (21): | 193.49 | |
Williams %R (14): | -76.31 | |
Chande Momentum Oscillator (20): | 0.45 | |
Repulse (5,40,3): | 0.2500 | |
ROCnROLL: | -1 | |
TRIX (15,9): | 0.1300 | |
Courbe Coppock: | 2.12 |
MA7: | 193.79 | |
MA20: | 195.11 | |
MA50: | 189.29 | |
MA100: | 176.44 | |
MAexp7: | 193.78 | |
MAexp20: | 193.96 | |
MAexp50: | 188.82 | |
MAexp100: | 181.07 | |
Price / MA7: | -0.28% | |
Price / MA20: | -0.95% | |
Price / MA50: | +2.09% | |
Price / MA100: | +9.53% | |
Price / MAexp7: | -0.27% | |
Price / MAexp20: | -0.37% | |
Price / MAexp50: | +2.35% | |
Price / MAexp100: | +6.73% |
News
Don't forget to follow the news on ABBVIE INC.. At the time of publication of this analysis, the latest news was as follows:
- AbbVie Receives Positive CHMP Opinion for Mirvetuximab Soravtansine (ELAHERE®) for the Treatment of Certain Adult Ovarian Cancer
- Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie to Develop Next-Generation Therapies for Glaucoma Management
- Allergan Aesthetics Launches BOTOX® Cosmetic (onabotulinumtoxinA) for Masseter Muscle Prominence (MMP) in Adults in China
- AbbVie Showcases Advancement of Solid Tumor Pipeline at ESMO 2024, with New Data in Tumor Types with High Unmet Needs
- AbbVie Declares Quarterly Dividend
Add a comment
Comments
0 comments on the analysis ABBVIE INC. - Daily